Mindfulness in the treatment of chronic pain and improvement in the quality of life of both oncological and non-oncological patients
Journal Title: OncoReview - Year 2016, Vol 6, Issue 2
Abstract
Pain, which accompanies almost every third Pole, is an ever greater medical, psychological and social challenge. Relieving pain, and chronic one in particular, is now becoming one of the most important tasks for contemporary health care systems. It involves searching for efficacious therapeutic methods, not only with respect to pharmacotherapy, but also psychotherapy, physiotherapy, surgery, and a combination of those forms of treatment. Mindfulness is one of the newest modalities of cognitive behavioural therapy, and as a method that supports pharmacological pain management, it appears to be an interesting and efficacious way of reducing subjective pain experience in both oncological and non-oncological patients. It may also have a positive impact on the quality of life, reducing disease-related depressive symptoms and anxiety. Current study results encourage us to continue research in the field, and to further assess the efficacy of mindfulness trainings in different realms of medicine.
Authors and Affiliations
Anna Kieszkowska-Grudny
Pericardial effusion endangering cardiac tamponade in cases of patients suffering for malignant diseases – diagnostics and management
Pericardial effusion endangering cardiac tamponade is a condition of high risk of life loss. In case of endangering cardiac tamponade the most important are: fast diagnosis, pericardiocentesis and drainage of the pericar...
Safety and efficacy of liposomal doxorubicin in a patient treated for metastatic breast cancer
Breast cancer is the most common malignancy among women in Poland and all over the world. Despite the development of modern therapies, cytostatics still play one of the main roles in treatment of this disease. Classic an...
Paraneoplastic neurological syndrome in the course of breast cancer
Paraneoplastic neurological syndromes (PNS) are a group of rarely observed disorders, accompanying about 1% of cancer diseases. They have a typically aggressive course, leading to profound and essentially irreversible di...
Report from the ESMO Conference on Sarcoma and GIST, 9–10 March 2012, Milan, Italy
In 9–10 March 2012, Milan (Italy), the conference organized by the European Society for Medical Oncology (ESMO) took place. The main topic of the conference was sarcomas and gastrointestinal stromal tumors (GIST). This c...
Imaging for Cardiotoxicity: Many Issues, Many Questions